EU – 12th Meeting of the Working Group on Guidelines on benefit – risk assessment of Phthalates in Medical Devices
Published in Phthalates and Scientific Committee on Health, Environmental and Emerging Risks (SCHEER)
More from PhthalatesMore posts in Phthalates »
- EU – Why are potential dangerous phthalates allowed in medical devices, and who decides if their use is warranted?
- Final guidance – GUIDELINES on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
- EU – Hearing on the SCHEER preliminary Guidelines on the presence of Phthalates in certain medical devices (Brussels, 04 April 2019) – Summary records and presentations now available
- PUBLIC CONSULTATION ON PHTHALATES IN MEDICAL DEVICES
More from Scientific Committee on Health, Environmental and Emerging Risks (SCHEER)More posts in Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) »
- EU – SCHEER – Minutes of the Working Group meeting on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) of 15 January 2020
- SCHEER Safety of breast implants WG – minutes of 4 November 2019 meeting
- EU – Minutes of the 24 July 2019 SCHEER Working Group on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) meeting
- EU – SCHEER – Minutes of the Working Group meeting on guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices of 8 January 2019
Be First to Comment